Insider Transactions for KalVista Pharmaceuticals, Inc. (KALV)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.CHIEF SCIENTIFIC OFFICERFeb 20, 2024Sale$14.0728,288397,92982,048Feb 21, 2024, 09:51 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherCHIEF DEVELOPMENT OFFICERFeb 20, 2024Sale$14.1112,053170,12472,895Feb 21, 2024, 09:48 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBOFeb 20, 2024Sale$14.1122,802321,846187,315Feb 21, 2024, 09:46 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.CHIEF MEDICAL OFFICERFeb 20, 2024Sale$14.1114,295201,77452,886Feb 21, 2024, 09:44 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOFeb 20, 2024Sale$14.1124,888351,289211,203Feb 21, 2024, 09:41 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBOFeb 14, 2024Sale$15.0140,855613,205159,088Feb 16, 2024, 04:21 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOFeb 14, 2024Sale$15.0158,356875,883181,676Feb 16, 2024, 04:20 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.CHIEF SCIENTIFIC OFFICERFeb 14, 2024Sale$15.0128,171422,82771,657Feb 16, 2024, 04:19 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherCHIEF DEVELOPMENT OFFICERFeb 14, 2024Sale$15.0139,886598,66166,160Feb 16, 2024, 04:18 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners EG, L.P.10% OwnerFeb 06, 2024Buy$14.744,47465,9474,743,157Feb 08, 2024, 08:11 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners III, L.P.10% OwnerFeb 07, 2024Buy$14.5651,827754,6014,794,984Feb 08, 2024, 08:11 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerFeb 08, 2024Buy$14.7029,747437,2814,824,731Feb 08, 2024, 08:11 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOFeb 01, 2024Sale$16.2210,000162,198118,232Feb 05, 2024, 05:55 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 30, 2024Buy$14.4788,0991,274,7934,738,683Feb 01, 2024, 04:38 PM
KALVKalVista Pharmaceuticals, Inc.VHCP Co-Investment Holdings III, LLC10% OwnerJan 25, 2024Buy$12.737,03089,4924,565,810Jan 29, 2024, 07:07 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners EG, L.P.10% OwnerJan 26, 2024Buy$12.984,17454,1794,569,984Jan 29, 2024, 07:07 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 29, 2024Buy$14.2280,6001,146,1324,650,584Jan 29, 2024, 07:07 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners EG, L.P.10% OwnerJan 24, 2024Buy$12.4420,686257,3344,558,780Jan 24, 2024, 08:24 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 22, 2024Buy$12.5567,546847,7024,527,197Jan 24, 2024, 08:24 PM
KALVKalVista Pharmaceuticals, Inc.Koh Bong Y10% OwnerJan 23, 2024Buy$12.5410,897136,6484,538,094Jan 24, 2024, 08:24 PM
KALVKalVista Pharmaceuticals, Inc.VHCP Co-Investment Holdings III, LLC10% OwnerJan 17, 2024Buy$12.6078,925994,4554,394,971Jan 19, 2024, 06:02 PM
KALVKalVista Pharmaceuticals, Inc.Koh Bong Y10% OwnerJan 18, 2024Buy$12.5139,680496,3974,434,651Jan 19, 2024, 06:02 PM
KALVKalVista Pharmaceuticals, Inc.Koh Bong Y10% OwnerJan 19, 2024Buy$12.4325,000310,7504,459,651Jan 19, 2024, 06:02 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners III, L.P.10% OwnerJan 11, 2024Buy$12.686,64784,2844,296,447Jan 16, 2024, 07:04 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 16, 2024Buy$12.7319,599249,4954,316,046Jan 16, 2024, 07:04 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJan 11, 2024Sale$13.0322,679295,51439,828Jan 12, 2024, 04:26 PM
KALVKalVista Pharmaceuticals, Inc.Koh Bong Y10% OwnerJan 08, 2024Buy$12.4469,184860,6494,221,284Jan 10, 2024, 08:57 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners III, L.P.10% OwnerJan 09, 2024Buy$12.5620,816261,4494,242,100Jan 10, 2024, 08:57 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 10, 2024Buy$12.6747,700604,3594,289,800Jan 10, 2024, 08:57 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJan 08, 2024Sale$13.0117,221224,00062,607Jan 10, 2024, 06:05 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJan 09, 2024Sale$13.001001,30062,507Jan 10, 2024, 06:05 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 03, 2024Buy$12.2017,605214,7814,110,336Jan 05, 2024, 04:13 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerJan 04, 2024Buy$12.1141,764505,7624,152,100Jan 05, 2024, 04:13 PM
KALVKalVista Pharmaceuticals, Inc.Venrock Healthcare Capital Partners EG, L.P.10% OwnerDec 29, 2023Buy$12.496,01375,1024,092,731Dec 29, 2023, 06:44 PM
KALVKalVista Pharmaceuticals, Inc.VHCP Management III, LLC10% OwnerDec 27, 2023Buy$11.9741,514496,9233,615,228Dec 29, 2023, 06:44 PM
KALVKalVista Pharmaceuticals, Inc.Shah Nimish P10% OwnerDec 28, 2023Buy$12.50471,4905,893,6254,086,718Dec 29, 2023, 06:44 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEODec 27, 2023Sale$12.0230,000360,453127,532Dec 28, 2023, 04:28 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerNov 20, 2023Sale$8.237,98565,71136,568Nov 21, 2023, 04:34 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerNov 20, 2023Sale$8.234,95840,80179,828Nov 21, 2023, 04:33 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 20, 2023Sale$8.237,11358,53546,046Nov 21, 2023, 04:32 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LPresident, CFO, CBO & Sec'yNov 20, 2023Sale$8.2313,008107,047112,443Nov 21, 2023, 04:31 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEONov 20, 2023Sale$8.2314,807121,851157,532Nov 21, 2023, 04:30 PM
KALVKalVista Pharmaceuticals, Inc.Cha AlbertDirectorSep 11, 2023Option Exercise$9.0036,000323,87018,000Sep 13, 2023, 04:29 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerAug 18, 2023Sale$10.738,02086,04526,023Aug 21, 2023, 08:09 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerAug 18, 2023Sale$10.734,97653,38673,289Aug 21, 2023, 08:07 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 18, 2023Sale$10.737,14276,62441,662Aug 21, 2023, 08:06 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LPresident, CFO, CBO & Sec'yAug 18, 2023Sale$10.7313,067140,19295,254Aug 21, 2023, 08:05 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOAug 18, 2023Sale$10.7314,876159,602146,756Aug 21, 2023, 08:05 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerMay 18, 2023Sale$10.142,60426,41637,310May 19, 2023, 09:20 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LPresident, CFO, CBO & Sec'yMay 18, 2023Sale$10.144,03740,95378,126May 19, 2023, 09:19 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerMay 18, 2023Sale$10.141,78618,11866,771May 19, 2023, 09:18 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOMay 18, 2023Sale$10.145,62757,083128,050May 19, 2023, 09:17 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerMay 18, 2023Sale$10.142,78028,20113,014May 19, 2023, 09:16 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerFeb 17, 2023Sale$7.663,41226,1369,347Feb 23, 2023, 05:44 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerFeb 17, 2023Sale$7.662,22817,06664,352Feb 23, 2023, 05:44 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerFeb 17, 2023Sale$7.662,72720,88935,709Feb 23, 2023, 05:42 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LPresident, CFO, CBO & Sec'yFeb 17, 2023Sale$7.664,95437,94872,799Feb 23, 2023, 05:41 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOFeb 17, 2023Sale$7.666,70051,322120,927Feb 23, 2023, 05:40 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 18, 2022Sale$5.441,1396,19634,232Nov 21, 2022, 04:21 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBO & SecretaryNov 18, 2022Sale$5.447223,92868,390Nov 21, 2022, 04:20 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerNov 18, 2022Sale$5.445302,88362,376Nov 21, 2022, 04:18 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEONov 18, 2022Sale$5.441,7859,710114,878Nov 21, 2022, 04:17 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerNov 18, 2022Sale$5.447223,9285,946Nov 21, 2022, 04:15 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOSep 02, 2022Sale$17.011,32022,458110,858Sep 07, 2022, 04:50 PM
KALVKalVista Pharmaceuticals, Inc.Audhya Paul K.Chief Medical OfficerAug 17, 2022Sale$14.9672510,8471,693Aug 19, 2022, 05:24 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerAug 17, 2022Sale$14.965327,96061,132Aug 19, 2022, 05:17 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 17, 2022Sale$14.961,14517,13033,597Aug 19, 2022, 05:16 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBO & SecretaryAug 17, 2022Sale$14.9672510,84766,693Aug 19, 2022, 05:15 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOAug 17, 2022Sale$14.961,79726,890112,178Aug 19, 2022, 04:58 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOMar 09, 2022Sale$17.0710,000170,693114,670Mar 11, 2022, 04:56 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJan 07, 2022Option Exercise$7.5457,657434,83259,891Jan 11, 2022, 04:42 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerNov 01, 2021Sale$18.076,000108,4242,234Nov 03, 2021, 05:00 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 01, 2021Sale$18.075,00090,32832,969Nov 03, 2021, 04:56 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOOct 01, 2021Sale$17.1810,000171,841124,670Oct 04, 2021, 04:57 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 02, 2021Sale$20.525,000102,57837,969Aug 04, 2021, 07:55 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerAug 02, 2021Sale$20.526,000123,1348,234Aug 04, 2021, 07:55 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOJul 01, 2021Sale$24.1510,000241,477140,320Jul 02, 2021, 05:35 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOJun 09, 2021Sale$30.058,933268,480145,737Jun 11, 2021, 07:29 PM
KALVKalVista Pharmaceuticals, Inc.Smith Michael DavidSenior VP, DevelopmentJun 01, 2021Sale$17.6115,000264,1467,500Jun 03, 2021, 06:28 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJun 02, 2021Sale$26.438,200216,69615,296Jun 03, 2021, 06:26 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerJun 01, 2021Sale$26.8125,800691,66522,448Jun 03, 2021, 06:26 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerMay 03, 2021Sale$17.5312,000210,31160,234May 06, 2021, 08:03 PM
KALVKalVista Pharmaceuticals, Inc.Smith Michael DavidSenior VP, DevelopmentApr 28, 2021Sale$17.0820,028342,00010,014Apr 30, 2021, 05:49 PM
KALVKalVista Pharmaceuticals, Inc.Maetzel AndreasSenior Vice President, MedicalApr 28, 2021Sale$16.6672,2541,203,74936,127Apr 29, 2021, 08:55 PM
KALVKalVista Pharmaceuticals, Inc.Maetzel AndreasSenior Vice President, MedicalApr 29, 2021Sale$17.8681,7721,460,61340,886Apr 29, 2021, 08:55 PM
KALVKalVista Pharmaceuticals, Inc.Maetzel AndreasSenior Vice President, MedicalApr 27, 2021Sale$16.8522,034371,30711,017Apr 29, 2021, 08:55 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOApr 01, 2021Sale$27.4410,000274,436168,720Apr 05, 2021, 06:38 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerFeb 23, 2021Sale$33.5915,000503,87762,169Feb 25, 2021, 08:25 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBO & SecretaryFeb 23, 2021Sale$20.1659,2841,195,34994,642Feb 25, 2021, 08:23 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerFeb 23, 2021Sale$33.6031,0001,041,64283,946Feb 25, 2021, 08:22 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOFeb 23, 2021Sale$33.5510,000335,538178,920Feb 25, 2021, 08:20 PM
KALVKalVista Pharmaceuticals, Inc.Crockett Thomas AndrewCEOJan 04, 2021Sale$18.1910,000181,904186,234Jan 06, 2021, 05:33 PM
KALVKalVista Pharmaceuticals, Inc.Palleiko Benjamin LCFO, CBO & SecretaryDec 30, 2020Option Exercise$13.397169,58832,858Jan 04, 2021, 06:06 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerNov 02, 2020Sale$17.146,000102,81272,734Nov 04, 2020, 05:03 PM
KALVKalVista Pharmaceuticals, Inc.Cha AlbertDirectorOct 30, 2020Buy$17.24115,6861,994,0681,138,179Nov 03, 2020, 07:56 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 29, 2020Sale$17.485,00087,39462,969Nov 02, 2020, 08:01 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 21, 2020Sale$18.256,044110,28270,513Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 20, 2020Sale$17.497,942138,88676,315Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerOct 20, 2020Sale$17.487,900138,09090,041Oct 22, 2020, 05:34 PM
KALVKalVista Pharmaceuticals, Inc.Feener Edward P.Chief Scientific OfficerOct 21, 2020Sale$18.319,007164,92884,141Oct 22, 2020, 05:34 PM